$244.540
-6.382 (-2.61%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
JAZZ Prediction & Forecast by Similar Chart Analysis
Alphio's JAZZ stock price prediction model matches the current Jazz Pharmaceuticals PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $245.66 (+0.46%). The 1-week path is $242.61 (-0.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Jazz Pharmaceuticals PLC Stock?
Jazz Pharmaceuticals appears to be a good buy right now due to its strong growth potential driven by the recent FDA approval of Ziihera, which has increased peak sales forecasts to $3B-$5B. The current price of $244.54 is well below the average analyst price target of $299, suggesting significant upside potential. Additionally, the company's gross margin has improved to 76.30% in Q2 2026, indicating strong profitability. However, the main risk is the negative earnings per share of -1.52 in Q1 2025, which highlights past volatility in earnings.
JAZZ stock price ended at $244.54 on Friday, after losing -2.61%
Jazz Pharmaceuticals PLC (JAZZ) last closed at $244.54, losing -2.61%. These facts feed the 1-day and 1-week JAZZ price prediction above.
Analyst Consensus
Jazz Pharmaceuticals PLC (JAZZ): 16 buy, 5 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Jazz Pharmaceuticals PLC (JAZZ) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches JAZZ, ranked by similarity.
Seasonality analysis for JAZZ
Historically the probability of a positive August return for JAZZ is 39.68%. March offers the highest probability of a positive month at 66.67%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for JAZZ
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $117.15 | $125.23 | $139.00 | -48.79% |
| Sep 2026 | $92.51 | $105.88 | $122.93 | -56.70% |
| Oct 2026 | $99.24 | $112.04 | $117.58 | -54.18% |
| Nov 2026 | $104.10 | $108.47 | $114.97 | -55.64% |
| Dec 2026 | $78.69 | $95.48 | $101.77 | -60.95% |
In 2026, Jazz Pharmaceuticals PLC (JAZZ) is projected to range from $78.69 to $139.00.
Jazz Pharmaceuticals PLC 2026 monthly forecast
In Aug 2026, Jazz Pharmaceuticals PLC is projected to average $125.23, with a low of $117.15 and high of $139.00.
In Sep 2026, Jazz Pharmaceuticals PLC is projected to average $105.88, with a low of $92.51 and high of $122.93.
In Oct 2026, Jazz Pharmaceuticals PLC is projected to average $112.04, with a low of $99.24 and high of $117.58.
In Nov 2026, Jazz Pharmaceuticals PLC is projected to average $108.47, with a low of $104.10 and high of $114.97.
In Dec 2026, Jazz Pharmaceuticals PLC is projected to average $95.48, with a low of $78.69 and high of $101.77.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.